Melbourne Dental School - Research Publications
Permanent URI for this collection
Search Results
1 - 5 of 5
-
ItemThe relationship between facial bone wall defects and dimensional alterations of the ridge following flapless tooth extraction in the anterior maxilla(WILEY, 2017-08)PURPOSE: To evaluate the relationship between defects of the facial socket wall at extraction and dimensional changes 8 weeks later in maxillary central and lateral incisor sockets. MATERIALS AND METHODS: A total of 34 consecutive patients requiring single tooth implants in the anterior maxilla (27 central and 7 lateral incisors) were evaluated. Orofacial external ridge, bone dimensions and the location of the socket bone crest were measured at extraction and again 8.5 ± 2.91 weeks later. The status of the facial bone wall was recorded at the same time points. RESULTS: At extraction, 16 of 34 sites (47%) had intact facial bone. There were fenestration defects at 9 of 34 sites (26.5%) and dehiscence defects at 9 of 34 sites (26.5%). A significant reduction (P < 0.001) in the external orofacial ridge dimension occurred (mesial 1.4 ± 1.30 mm or 12.1%, facial 2.5 ± 1.46 mm or 22.2%, distal 1.1 ± 0.83 mm or 10.5%), with greatest change at dehiscence (3.3 ± 1.80 mm or 28.4%) and fenestration sites (2.8 ± 1.40 mm or 24.9%). A significant reduction in orofacial bone dimension occurred (mesial 0.8 ± 0.80 mm or 9.3%, P < 0.001; facial 1.2 ± 1.03 mm or 18.3%, P < 0.001; distal 0.4 ± 0.65 mm or 5.5%, P < 0.01). Vertical resorption of the bone crest was most marked at the mid-facial aspect (1.4 ± 1.94 mm, P < 0.001). Initial fenestration defect sites demonstrated the greatest vertical dimensional change (2.9 ± 2.67 mm; P = 0.008). Of 16 sites with initially intact facial bone, 9 sites (56.3%) developed dehiscence defects after 8 weeks. Of the 9 initial sites with fenestration defects, 5 (55.6%) turned into dehiscence defects. All 9 sites with initial dehiscence defects healed with persistence of the dehiscence. CONCLUSIONS: Eight weeks after flapless extraction of maxillary central and lateral incisors, a reduction in the orofacial dimensions of the ridge was observed due to resorption of the facial bone of the socket. Tooth type (maxillary central incisor) and thin tissue phenotype significantly influenced the outcomes. The dimensional alterations were most pronounced at sites that initially had fenestration and dehiscence defects of the facial bone.
-
ItemThe influence of deproteinised bovine bone mineral on dimensional changes in the maxillary second incisor socket(WILEY, 2019-07)OBJECTIVES: To investigate the dimensional changes following the extraction of maxillary second incisors and to evaluate the influence of deproteinised bovine bone mineral on the healing outcomes. MATERIALS AND METHODS: The second maxillary incisors in nine dogs were extracted bilaterally in a minimally traumatic manner. Deproteinised bovine bone mineral with collagen (DBBMC) and a collagen matrix (CM) was placed in one socket with the contralateral socket left to heal naturally. After 3 months of healing, the dogs were sacrificed and the pre-maxilla resected. Cone beam computerised tomography scans (CBCTs) were obtained and the specimens prepared for histological preparation and analysis. Surface scans of study models taken pre- and post-extraction were digitally subtracted to analyse volumetric changes. RESULTS: All dogs healed uneventfully without any complications. No inflammation was seen, and DBBMC was well integrated into a network of mineralised tissues, bone marrow and connective tissue. The horizontal width of the buccal crest was found to be significantly greater in grafted sockets, but the vertical height to be similar. No significant difference was seen in regard to volumetric changes in sockets over 3 months post-extraction. CONCLUSION: Maxillary second incisor sockets of dogs grafted with DBBMC post-extraction had significantly greater horizontal width at the ridge crest compared with ungrafted sockets. Volumetric analysis revealed no significant difference between grafted and non-grafted sockets, suggesting possible soft tissue thickening post-extraction to counteract osseous resorption.
-
ItemMarginal bone level and survival of short and standard-length implants after 3 years: An Open Multi-Center Randomized Controlled Clinical Trial(WILEY, 2018-08)OBJECTIVES: The present multi-center randomized controlled clinical trial sought to compare the marginal bone level (MBL) changes and survival of 6- and 11-mm implants. MATERIAL AND METHODS: Ninety-five patients receiving a total of 209 dental implants were enrolled. Subjects were randomly allocated to two cohorts: test (4.0 × 6 mm; N = 108) or control (4.0 × 11 mm; N = 101) implant groups. To be randomized, all edentulous sites were anatomically qualified to receive 11 mm implant. Two to three implants were placed in maxillary or mandibular posterior regions and loaded with splinted provisional restoration after 6 weeks and definitive restoration 6 months thereafter. Test and control implants were followed by clinical and radiographic examinations on an annual basis up to 3 years. RESULTS: Radiographic assessment of MBL 3 years after loading revealed the bone to be located at 0.27 mm (±0.40) and 0.44 mm (±0.74) apical to the implant platform in the test and control groups, respectively. During the 3 years of follow-up since loading, 0.04 mm (±0.43) MBL gain and 0.02 mm (±0.76) of MBL loss were observed in the 6-mm (test) and 11-mm (control) groups, respectively. The MBL's for test and control were significantly different (p = 0.000) in favor of short implants. The cumulative survival rates from placement after 3 years were 96% and 99% for the 6- and 11-mm implants, respectively, with no statistical significance. CONCLUSIONS: Reconstruction of partially edentulous posterior maxilla or mandible with 6- or 11-mm implants led to stable marginal bone level and high implant survival rate after 3 years.
-
ItemPeri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions(WILEY, 2018-06)A classification for peri-implant diseases and conditions was presented. Focused questions on the characteristics of peri-implant health, peri-implant mucositis, peri-implantitis, and soft- and hard-tissue deficiencies were addressed. Peri-implant health is characterized by the absence of erythema, bleeding on probing, swelling, and suppuration. It is not possible to define a range of probing depths compatible with health; Peri-implant health can exist around implants with reduced bone support. The main clinical characteristic of peri-implant mucositis is bleeding on gentle probing. Erythema, swelling, and/or suppuration may also be present. An increase in probing depth is often observed in the presence of peri-implant mucositis due to swelling or decrease in probing resistance. There is strong evidence from animal and human experimental studies that plaque is the etiological factor for peri-implant mucositis. Peri-implantitis is a plaque-associated pathological condition occurring in tissues around dental implants, characterized by inflammation in the peri-implant mucosa and subsequent progressive loss of supporting bone. Peri-implantitis sites exhibit clinical signs of inflammation, bleeding on probing, and/or suppuration, increased probing depths and/or recession of the mucosal margin in addition to radiographic bone loss. The evidence is equivocal regarding the effect of keratinized mucosa on the long-term health of the peri-implant tissue. It appears, however, that keratinized mucosa may have advantages regarding patient comfort and ease of plaque removal. Case definitions in day-to-day clinical practice and in epidemiological or disease-surveillance studies for peri-implant health, peri-implant mucositis, and peri-implantitis were introduced. The proposed case definitions should be viewed within the context that there is no generic implant and that there are numerous implant designs with different surface characteristics, surgical and loading protocols. It is recommended that the clinician obtain baseline radiographic and probing measurements following the completion of the implant-supported prosthesis.
-
ItemSubmerged and transmucosal healing yield the same clinical outcomes with two-piece implants in the anterior maxilla and mandible: interim 1-year results of a randomized, controlled clinical trial(WILEY-BLACKWELL, 2012-02)OBJECTIVES: To test whether or not transmucosal healing at two-piece implants is as successful as submerged placement regarding crestal bone levels and patient satisfaction. MATERIAL AND METHODS: Adults requiring implants in the anterior maxilla or mandible in regions 21-25, 11-15, 31-35 or 41-45 (WHO) were recruited for this randomized, controlled multi-center clinical trial of a 5-year duration. Randomization was performed at implantation allowing for either submerged or transmucosal healing. Final reconstructions were seated 6 months after implantation. Radiographic interproximal crestal bone levels and peri-implant soft tissue parameters were measured at implant placement (IP) (baseline), 6 and 12 months. Patient satisfaction was assessed by a questionnaire. A two-sided t-test (80% power, significance level α=0.05) was performed on bone-level changes at 6 and 12 months. RESULTS: One hundred and twenty-seven subjects were included in the 12-month analysis (submerged [S]: 52.5%, transmucosal [TM]: 47.2%). From IP to 6 months, the change in the crestal bone level was -0.32 mm (P<0.001) for the S group and -0.29 mm (P<0.001) for the TM group. From IP to 12 months, bone-level changes were statistically significant in both groups (S -0.47 mm, P<0.001; TM -0.48 mm, P<0.001). The mean differences of change in the bone levels between the two groups were not statistically significant at either time point, indicating the equivalence of both procedures. For both groups, very good results were obtained for soft tissue parameters and for patient satisfaction. CONCLUSIONS: Transmucosal healing of two-piece implants is as successful as the submerged healing mode with respect to tissue integration and patient satisfaction within the first 12 months after IP.